Drug Institutions
A directory of global drug formularies, national regulators and Health Technology Assessment (HTA) bodies — the international equivalents of the BNF and NICE — grouped by region.
ABOUT THIS DIRECTORY
Two distinct categories are represented: Drug References / Formularies (comprehensive databases of drug monographs, dosing, interactions and side effects) and Health Technology Assessment (HTA) Bodies (organisations that evaluate the clinical and cost-effectiveness of medicines to inform funding, pricing and national guidelines). National medicines regulators are also included where relevant.
CATEGORY
REGION
International & Pan-European
North America
Institute for Clinical and Economic Review (ICER)
United States
HTAIndependent non-profit that evaluates the clinical and cost-effectiveness of drugs; reports widely used by US payers.
AHFS Drug Information (AHFS DI)
United States
FormularyAuthoritative US drug compendium published by the American Society of Health-System Pharmacists.
Prescribers' Digital Reference (PDR)
United States
FormularyWidely used US prescribing reference for clinicians.
DailyMed
United States
FormularyNIH-hosted repository of official FDA-approved manufacturer drug labels.
Canada's Drug Agency (CDA-AMC)
Canada
HTANational HTA body (formerly CADTH) evaluating drugs and health technologies for most of Canada.
Institut national d'excellence en santé et en services sociaux (INESSS)
Canada (Québec)
HTAQuébec's HTA body, evaluating drugs and health technologies for the province.
Compendium of Pharmaceuticals and Specialties (CPS)
Canada
FormularyCanada's national drug reference, published by the Canadian Pharmacists Association.
Asia-Pacific
Pharmaceutical Benefits Advisory Committee (PBAC)
Australia
HTAStatutory body that evaluates therapies for subsidy under Australia's Pharmaceutical Benefits Scheme (PBS).
Australian Medicines Handbook (AMH)
Australia
FormularyAustralia's national independent drug reference for prescribers.
Pharmaceutical Management Agency (PHARMAC)
New Zealand
HTAGovernment agency that decides which medicines and devices are publicly funded.
New Zealand Formulary (NZF)
New Zealand
FormularyNew Zealand's national drug formulary for prescribers and pharmacists.
Europe
Haute Autorité de Santé (HAS)
France
HTAEvaluates the clinical benefit and economic value of health technologies to guide reimbursement in France.
Vidal
France
FormularyDefinitive commercial drug reference used by French clinicians.
Federal Joint Committee (G-BA)
Germany
HTAMakes legally binding funding decisions for the German statutory health insurance system.
Institute for Quality and Efficiency in Health Care (IQWiG)
Germany
HTAProvides scientific assessments of drugs and health technologies that inform G-BA decisions.
Rote Liste
Germany
FormularyPrimary German directory of prescription medicines (the "Red List").
Gelbe Liste
Germany
FormularyGerman drug directory and prescribing information (the "Yellow List").
Health Information and Quality Authority (HIQA)
Ireland
HTAIreland's national HTA and quality body for health and social care.
National Centre for Pharmacoeconomics (NCPE)
Ireland
HTAConducts pharmacoeconomic evaluations of medicines to inform reimbursement in Ireland.
Spanish Agency of Medicines and Medical Devices (AEMPS)
Spain
RegulatorSpain's national medicines regulator.
Agency for Health Quality and Assessment of Catalonia (AQuAS)
Spain (Catalonia)
HTARegional HTA body for Catalonia.
Italian Medicines Agency (AIFA)
Italy
RegulatorItaly's national medicines regulator, also handling pricing and reimbursement.
Dental and Pharmaceutical Benefits Agency (TLV)
Sweden
HTADecides which medicines and dental treatments are subsidised in Sweden.
Swedish Agency for Health Technology Assessment (SBU)
Sweden
HTAIndependent national body assessing health technologies and clinical practice in Sweden.
Zorginstituut Nederland (ZIN)
Netherlands
HTANational Healthcare Institute advising on the basic insurance package and reimbursement.
United Kingdom
National Institute for Health and Care Excellence (NICE)
United Kingdom (England)
HTAPrimary HTA body for England, producing guidance on medicines and clinical care.
Scottish Medicines Consortium (SMC)
United Kingdom (Scotland)
HTAAdvises NHS Scotland on the clinical and cost-effectiveness of newly licensed medicines.
All Wales Medicines Strategy Group (AWMSG)
United Kingdom (Wales)
HTAProvides advice on medicines to the Welsh Government and NHS Wales.
Tap an institution to see its category, region and key links.
Logos are copyright each respective Institution. All Rights Reserved.